BANK VONTOBEL/PUT/WALGREENS BOOTS ALLIANCE/19/0.1/20.12.24 Stock

Warrant

DE000VD3SDD3

Real-time Boerse Frankfurt Warrants 04:16:53 2024-06-21 am EDT
0.4 EUR +2.56% Intraday chart for BANK VONTOBEL/PUT/WALGREENS BOOTS ALLIANCE/19/0.1/20.12.24
Current month+2.63%
1 month+50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-21 0.4 +2.56%
24-06-20 0.39 +2.63%
24-06-19 0.38 -5.00%
24-06-18 0.4 -9.09%
24-06-17 0.44 +2.33%

Real-time Boerse Frankfurt Warrants

Last update June 21, 2024 at 04:16 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SDD
ISINDE000VD3SDD3
Date issued 2024-04-09
Strike 19 $
Maturity 2024-12-20 (183 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.25
Spread 0.01
Spread %2.44%

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.87 USD
Average target price
22.21 USD
Spread / Average Target
+39.94%
Consensus